跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ambigrast - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ambigrast
Approved
STANDARD
Ambigrast
Reliance Life Sciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
75c1ee87ec4e2875
Company
Reliance Life Sciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
75c1ee87ec4e2875
Drug Approval Philippines Name
Ambigrast
Product Name
Ambigrast
Registration Number
BRP-051
Brand Name
Ambigrast
Generic Name
Filgrastim
Dosage Form
Solution For Injection (Iv/Sc)
Dosage Strength
300 mcg/ 0.5 mL
Manufacturer
Reliance Life Sciences Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
29 February 2024
Expiry Date
07 August 2029
Pharmacologic Category
Colony Stimulating Factor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
75c1ee87ec4e2875
Type
Standard
Back to Philippines FDA Approvals